Drugs / Th2/Tc2 cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00079625 | Mar 2004 → Aug 2013 | breast neoplasm | National Cancer Institute (NCI) | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Th2/Tc2 cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00079625 ↗ |